DYNACIRC Drug Patent Profile
✉ Email this page to a colleague
When do Dynacirc patents expire, and what generic alternatives are available?
Dynacirc is a drug marketed by Smithkline Beecham and Glaxosmithkline Llc and is included in two NDAs.
The generic ingredient in DYNACIRC is isradipine. There are seven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the isradipine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dynacirc
A generic version of DYNACIRC was approved as isradipine by WATSON LABS TEVA on January 5th, 2006.
Summary for DYNACIRC
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 119 |
Clinical Trials: | 3 |
Patent Applications: | 4,300 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DYNACIRC at DailyMed |
Recent Clinical Trials for DYNACIRC
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
National Institute on Drug Abuse (NIDA) | Early Phase 1 |
University of Texas at Austin | Early Phase 1 |
The Parkinson Study Group | Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for DYNACIRC
US Patents and Regulatory Information for DYNACIRC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Smithkline Beecham | DYNACIRC | isradipine | CAPSULE;ORAL | 019546-001 | Dec 20, 1990 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Glaxosmithkline Llc | DYNACIRC CR | isradipine | TABLET, EXTENDED RELEASE;ORAL | 020336-002 | Jun 1, 1994 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Smithkline Beecham | DYNACIRC | isradipine | CAPSULE;ORAL | 019546-002 | Dec 20, 1990 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Glaxosmithkline Llc | DYNACIRC CR | isradipine | TABLET, EXTENDED RELEASE;ORAL | 020336-001 | Jun 1, 1994 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for DYNACIRC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Smithkline Beecham | DYNACIRC | isradipine | CAPSULE;ORAL | 019546-001 | Dec 20, 1990 | ⤷ Try a Trial | ⤷ Try a Trial |
Smithkline Beecham | DYNACIRC | isradipine | CAPSULE;ORAL | 019546-002 | Dec 20, 1990 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for DYNACIRC
See the table below for patents covering DYNACIRC around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Sweden | 445219 | 1,4-DIHYDROPYRIDINDERIVAT, FORFARANDE FOR FRAMSTELLNING DERAV SAMT FARMACEUTISK KOMPOSITION | ⤷ Try a Trial |
European Patent Office | 0000150 | DIHYDROPYRIDINE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | ⤷ Try a Trial |
Denmark | 149855 | ⤷ Try a Trial | |
Portugal | 70601 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |